Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Eli Lilly and Company (LLY) had Revenue of $15.56B for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$15.56B
Net Income	$5.66B
Cost of Goods Sold	$2.45B
Gross Profit	$13.11B
Operating Expenses	$8.69B
Operating Income	$6.87B
Non-Operating Income/Expense	$-90.60M
Pre-Tax Income	$6.78B
Normalized Pre-Tax Income	$6.78B
Income after Taxes	$5.66B
Income from Continuous Operations	$5.66B
Consolidated Net Income/Loss	$5.66B
Normalized Income after Taxes	$5.66B
EBIT	$6.87B
EBITDA	$7.35B
Weighted-Average Shares Outstanding (Basic)	897.90M
Weighted-Average Shares Outstanding (Diluted)	899.80M
Earnings per Share (EPS) (Basic)	$6.30
Earnings per Share (EPS) (Diluted)	$6.29
Balance Sheet Financials
Current Assets	$49.85B
Property, Plant, and Equipment	$20.53B
Long-Term Assets	$51.07B
Total Assets	$100.92B
Current Liabilities	$39.02B
Long-Term Debt	$34.18B
Long-Term Liabilities	$43.55B
Total Liabilities	$82.57B
Common Equity	$18.35B
Tangible Shareholders Equity	$6.67B
Shareholders Equity	$18.35B
Common Shares Outstanding	947.20M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$4.75B
Cash Flow from Investing Activities	$-5.19B
Cash Flow from Financial Activities	$134.80M
Beginning Cash	$3.27B
End Cash	$3.38B
Increase/Decrease in Cash	$107.50M
Stock-Based Compensation	$338.80M
Common Stock Dividends Paid	$-2.69B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.28
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.65
Debt to Equity Ratio	2.55
Gross Margin	84.27%
Operating Margin	44.14%
EBIT Margin	44.14%
EBITDA Margin	--
Pre-Tax Profit Margin	43.56%
Profit Margin	36.38%
Free Cash Flow	$1.55B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.15
Inventory Turnover	0.22
Receiveable Turnover	0.90
Days Sales in Receivables	99.53
Return on Equity	30.85%
Return on Tangible Equity	84.86%
Return on Assets	5.61%
Return on Investments	10.78%
Book Value Per Share	$19.37
Free Cash Flow per Share	$1.72
Operating Cash Flow per Share	$5.28

Data from Zacks Investment Research, Inc.